Skip to main content
. 2014 Oct 27;12(4):287–292. doi: 10.5217/ir.2014.12.4.287

Table 2.

The Decrease of CDAI Compared With Baseline at Week 4, 8 and 12

graphic file with name ir-12-287-i002.jpg

Valuses are presented as mean±SD or % (n).

*There were 6 patients who received adalimumab due to persistent abdominal fistula and the baseline CDAI <150.

CR-70, decrease in CDAI of at least 70 points; CR-100, decrease in CDAI of at least 100 points; CR-150, decrease in CDAI of at least 150 points.